stimulant medications refer to drugs that alter the activity in the frontostriatal region of the brain by impacting three (3) or more neurotransmitters important to the functioning of this region—dopamine , norepinephrine , and epinephrine, and possibly serotonin .

Related Articles

Stimulant Medications at■■■■■■■■■■
Stimulant Medications: Stimulant Medications refer to drugs that alter the activity in the frontostriatal . . . Read More
MAOIs (Monoamine oxidase inhibitors) at■■■■■■■■
MAOIs (Monoamine oxidase inhibitors): MAOIs (Monoamine oxidase inhibitors) refer to the group of antidepressant . . . Read More
Atypical antidepressants at■■■■■■
Atypical antidepressants: Atypical antidepressants refer to a recently developed group of medications . . . Read More
Monoamine at■■■■■■
Monoamine: Monoamine refers to non-acidic neurotransmitter  containing an amine group (NH2), formed . . . Read More
Anticholinergic agents at■■■■■
Anticholinergic agents: Anticholinergic agents refer to medication drugs that block the action of acetylcholine . . . Read More
Selective Serotonin Reuptake Inhibitors at■■■■■
Selective Serotonin Reuptake Inhibitors: Selective Serotonin Reuptake Inhibitors refers to a drug that . . . Read More
Catecholamines at■■■■■
Catecholamines: Catecholamines refer to organic compounds, including Epinephrine, Norepinephrine, and . . . Read More
Dopamine at■■■■■
Dopamine: Dopamine refers to neurotransmitter whose generalized function is to activate other neurotransmitters . . . Read More
Monoamine oxidase (MAO) inhibitors at■■■■■
Monoamine oxidase (MAO) inhibitors: Monoamine oxidase (MAO) inhibitors refers to drugs used to treat . . . Read More
Biomedical therapies at■■■■■
Biomedical therapies: Biomedical therapies refer to physiological interventions intended to reduce symptoms . . . Read More